Prostate Cancer Ontology
Center for Systems Biology, Sichuan University West China Hospital, Sichuan China
跳过导航链接。
折叠 前列腺癌前列腺癌
展开 前列腺癌流行病学前列腺癌流行病学
展开 前列腺癌的诊断前列腺癌的诊断
折叠 前列腺癌的治疗前列腺癌的治疗
展开 延期治疗延期治疗
展开 外科手术外科手术
展开 放射疗法放射疗法
展开 冷冻疗法冷冻疗法
展开 激素疗法激素疗法
展开 化疗化疗
展开 去势抵抗性前列腺癌(CRPC)去势抵抗性前列腺癌(CRPC)
展开 转移性前列腺癌转移性前列腺癌
折叠 其他治疗方式其他治疗方式
展开 老年男性前列腺癌的治疗老年男性前列腺癌的治疗
展开 局部前列腺癌除手术和放疗以外的其他初级治疗选择局部前列腺癌除手术和放疗以外的其他初级治疗选择
折叠 局部前列腺癌患者的治疗后生活质量局部前列腺癌患者的治疗后生活质量
展开 根治性目的治疗后仅限PSA复发的治疗根治性目的治疗后仅限PSA复发的治疗
主动监视和等待观察
Preferred Name Active surveillance and watchful waiting
Definition Although active surveillance (AS) and watchful waiting (WW) avoids treatment-related side effects, they carry an increased risk of psychological distress, which significantly affects HRQoL. Risk factors for not doing well on AS include: patient perception that the physician is making most of the decisions, poor physical health,high anxiety, high PSA, lack of a partner, mental impairment, recent diagnosis of PCa, and lower number of core samples taken at diagnostic biopsy. These factors are significantly associated with low HRQoL. Anxiety and distress remained low during the first 9 months of AS.
Synonyms & Abbreviations Active surveillance and watchful waiting
ReferenceCode NA
ReferenceURL NA
PMID NA
Copyright (C) 2022 Institutes for Systems Genetics, Sichuan University West China Hospital. All Rights Reserved.